GlassScriptPhysician profile
Priscilla Campos
NPI 1073260592
$746.59
in general payments reported to CMS, 2019-2025
17 companies · $18.14 in 2025
The $18.14 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14.89 · 2023: $189 · 2024: $525 · 2025: $18.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $731.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $93.18 | 2023-2025 | |
| Pfizer INC. | $80.31 | 2024 | |
| Genentech USA, INC. | $77.77 | 2023-2024 | Ocrevus, Enspryng |
| Ucb, INC. | $71.49 | 2023-2024 | Rystiggo |
| Teva Pharmaceuticals USA, INC. | $58.13 | 2023-2024 | Austedo Xr, Ajovy |
| Novartis Pharmaceuticals Corporation | $51.63 | 2024 | |
| Cardiva Medical, INC. | $46.14 | 2023 | Cardiva Vascade 6/7f Vcs |
| Medtronic, INC. | $45.53 | 2024 | Ellipsys Vascular Access System |
| Lilly USA, LLC | $40.54 | 2024 | Amyvid, Emgality |
| Sk Life Science, INC. | $36.73 | 2024 | |
| Biogen, INC. | $33.56 | 2024 | Skyclarys, Vumerity, Tysabri |
| Amneal Pharmaceuticals LLC | $30.62 | 2024 | Rytary |
| Takeda Pharmaceuticals U.S.A., INC. | $20.01 | 2024 | Hyqvia |
| Kedrion Biopharma, INC. | $17.71 | 2024 | Kedrab, Gammaked, Koate |
| Lundbeck LLC | $14.93 | 2024 | Vyepti |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $14.89 | 2022 | |
| Scilex Pharmaceuticals INC. | $13.42 | 2023 | Ztlido |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priscilla Campos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.